The fresh capital provides another shot for Moderna's candidate against bird flu, which earlier this year lost its government ...
Orforglipron helped keep weight down when used after initial therapy with an injectable, a new treatment strategy that could ...
The company’s valuation, which surged past $40 billion this year, fell by almost a fifth on a dimmer outlook for its closely ...
The results position Takeda, which acquired its therapy in one of the industry’s larger single-drug acquisitions, to ...
The financing follows a strategic shift for Orum, which shelved its original lead program and is now pursuing a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback